Public comment on the new guidelines from the U.S. Preventative Services Task Force is open through May 8.
By Laura Santhanam
Men hoping to avoid some side effects of prostate cancer treatment are shelling out tens of thousands of dollars for a procedure whose long-term effects are unknown and insurers, including Medicare, won’t pay for.
By Julie Appleby, Kaiser Health News
A recent study, published online by the Journal of Men’s Health, indicates an increased risk for prostate cancer in male cyclists over the age of 50.
By Nora Daly
The U.S. Preventive Services Task Force said Friday that prostate specific antigen tests, known as PSAs, that are done to detect prostate cancer could be doing more harm than good. Jeffrey Brown discusses the latest controversial recommendation from the influential…
By PBS NewsHour
New cancer rates in the United States have declined for the first time and the cancer death rate among men and women has continued to drop, according to an annual report on cancer published Tuesday in the Journal of the…
The PSA blood test now used to screen for prostate cancer may predict how aggressively the cancer will spread, according to a study published Thursday in the New England Journal of Medicine.
The widely used screening test for prostate cancer did not detect most tumors, according to a study published Thursday in the New England Journal of Medicine.
Scientists announced Tuesday that a drug already on the market appears to reduce men's overall risk of developing prostate cancer, but also carries several serious side effects and may increase the risk of developing an aggressive tumor.
Scientists have identified a gene that plays a key role in whether prostate cancer spreads to other parts of the body or remains in the gland, where it is much less likely to cause harm, a study published Wednesday said.
Support Provided By: Learn more